AHR and asthma: In summary, our studies using two different murine model of asthma demonstrate that TAS2R agonists chloroquine and quinine administered by aerosol or intranasal route inhibit allergen-induced airway inflammation, remodeling, mucus production and AHR, four cardinal features of human asthma.